Skip to main content

Table 2 (abstract A44). See text for description

From: Proceedings of the 2019 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Annual Scientific Meeting

  Hypertensive BP at baseline (n=30) Normotensive BP at baseline (n=191) Hypertensive BP at follow up (n=131) Normotensive BP at follow up (n=90)
Minority race % (n) 77 (23) 64 (121) 69.4 (91) 60 (53)
Renal disease % (n) 57 (17) 41 (77) 49.6 (65) 32.6 (29)
Proliferative LN % (n) 23 (7) 26 (50) 33.6 (44) 19 (17)
Mean BMI kg/m2 (SD) 26.3 (6.3) 24 (5.1) 25.2 (5.7) 23.2 (4.4)
Mean duration of SLE, months 27.6 31.7 33.6 26.7
ACEI ever 60 (18) 36 (69) 44 (58) 31 (28)
  1. Characteristics of patients with hypertension at baseline and follow up within the APPLE cohort